Episode 8 – How Real-World Data is Transforming FDA Approvals, Healthcare Decisions, and Drug Development with Dr. Richard Scranton

Key Topics Discussed

• Introduction to Dr. Richard Scranton: From Navy clinician to biotech executive, Dr. Scranton shares his unique career path and early exposure to healthcare data systems.
• Real-World Data for Regulatory Innovation: Examples of leveraging RWD to expedite FDA approvals and demonstrate safety and efficacy, especially in pediatric care.
• Shifting the Regulatory Focus: Moving beyond harm identification to identify and quantify unexpected treatment benefits through RWE.
• The Role of AI in Surgery: Opportunities for artificial intelligence and machine learning to streamline clinical trials, optimize workflows, and enhance decision-making in the OR.
• Iterative Quality Improvement: How continuous data collection drives iterative improvements in surgical techniques, patient outcomes, and cost management.
• Advancing Pediatric Care: The untapped potential of RWD to support pediatric surgical innovation, expanding access to life-saving interventions.

Listen To the Episode

Spotify

Apple Podcasts

Watch on YouTube

Resources Mentioned

Lyndra Therapeutics

Book – Blind Spots: When Medicine Gets it Wrong, and What it Means for Our Health by Marty Makary, MD

TED Talk – Choice, Happiness, and Spaghetti Sauce l Malcolm Gladwell

Renowned pioneer in medical advancements and innovation – Robert (Bob) Langer

FDA Premarket Approval (PMA)

European Union (EU) Medical Device Regulation (MDR)

FDA Investigational Device Exemption (IDE) and IDE Approval Process

Additional Resources

Contact the podcast team with comments and questions for Dr. Bruce Ramshaw